Compare ZLAB & FULTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZLAB | FULTP |
|---|---|---|
| Founded | 2013 | N/A |
| Country | China | United States |
| Employees | N/A | 3400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | N/A |
| IPO Year | 2017 | N/A |
| Metric | ZLAB | FULTP |
|---|---|---|
| Price | $17.64 | $19.14 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $57.22 | N/A |
| AVG Volume (30 Days) | ★ 840.9K | N/A |
| Earning Date | 11-06-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $441,629,000.00 | N/A |
| Revenue This Year | $26.16 | N/A |
| Revenue Next Year | $30.62 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 24.14 | N/A |
| 52 Week Low | $16.82 | N/A |
| 52 Week High | $44.34 | N/A |
| Indicator | ZLAB | FULTP |
|---|---|---|
| Relative Strength Index (RSI) | 35.50 | 34.56 |
| Support Level | $17.50 | $19.06 |
| Resistance Level | $17.97 | $19.33 |
| Average True Range (ATR) | 0.62 | 0.19 |
| MACD | 0.26 | -0.02 |
| Stochastic Oscillator | 37.90 | 28.57 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.